Long-Acting Insulin Market
Long-Acting Insulin Market Share Analysis By Product Type (Insulin Detemir, Insulin Glargine, Insulin Degludec), By Indication (Type 1 diabetes, Type 2 diabetes), By Delivery method (Pump, Needle & Syringe, Injection port), By Distribution Channel, By Region - Global Insights 2021 to 2031
Analysis of Long-Acting Insulin Market Covering 30 + Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Long-Acting Insulin Market Forecast and CAGR
According to the latest research by Fact MR, long-acting insulin market will experience substantial growth with a CAGR of 9.4% during the forecast period 2021-2031. Insulin is a hormone that is produced by the pancreases to regulate blood sugar levels. Sometimes this hormone is deficient in individuals and resulting in diabetes. Long-acting insulin can be given for both type 1 and type 2 diabetes. The market is mainly driven by the rise in prevalence of diabetes, increasing geriatric population, new product launches and increase in research and development.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Driving Demand for Long-Acting Insulin?
To regulate the blood sugar levels, insulin treatment is given to the individual, which will mimic the physiological insulin secretion. The long-acting insulin is usually taken once a day and it lasts for the entire day.
The major factors driving the demand for long-acting insulin is the rise in prevalence of diabetes, increasing geriatric population, new product launches and increase in research and development. According to a report, by 2045, globally there will be 438 million people between 20-64 years who will be suffering from diabetes. Diabetes can also be caused due to overweight and obesity. According to WHO, at least 2.8 million people die due to obesity or being overweight. These people are at a higher risk of developing type 2 diabetes. This rise in the prevalence of diabetes and obesity will drive the market. According to a UN report, the geriatric population will increase from 9.3 per cent in 2020 to around 16.0 per cent in 2050. Due to the combined effect of impaired pancreatic islet function and increasing insulin resistance with ageing, this population are at a higher risk of developing type 2 diabetes.
Moreover, awareness about the current treatments by the population plays a crucial role in the surge in demand for long-acting insulin surgery during the forecast period.
Impact of COVID on Long-Acting Insulin Market
Due to the COVID-19 pandemic and restrictions in travelling and lockdown, the individuals were working from home. This resulted in a change in the lifestyle of people and eating habits. This also resulted in a decrease in physical activities. As a result, there was an increase in weight gain and the prevalence of diabetes during this time. Moreover, people with diabetes are more likely to have complications due to COVID. Therefore, the market saw a positive impact due to COVID.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Regional Outlook for Long-Acting Insulin
The market is dominated by the European region. This is due to the presence of major players in the market. Out of the three major players of long-acting insulin, two are present in Europe and are distributors of insulin in many low and middle-income countries and also in high-income countries. Apart from this, the geriatric population is high in this region. For instance, as per Eurostat reported data in 2020, more than 20 % of the total population of Europe is above the age of 65.
Followed by Europe, North America is dominating the market with countries like U.S. and Canada. These countries have the best healthcare infrastructure and the presence of the major players. The market is mainly driven by acquisition and collaboration.
Who are the Key Manufacturers and Suppliers of Long-Acting Insulin?
Some of the leading manufacturers operating in the long-acting insulin include
- Ganli Pharmaceutical Co. Ltd
- Sanofi-Aventis U.S. LLC
- Lilly USA
- LLC
- Novo Nordisk A/S
- Biocon
- Wockhardt
- Mylan
- Julphar
Many leading manufacturers in the Long-Acting Insulin are focusing on launching new products. For instance, in August 2020, Mylan and Biocon in collaboration launched Semglee, an insulin glargine injection in the U.S.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Long-Acting Insulin Market Report Highlights:
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Key Segments
-
By Product Type :
- Detemir
- Glargine
- Degludec
-
By Indication :
- Type 1 diabetes
- Type 2 diabetes
-
By Delivery method :
- Pump
- Needle and syringe
- Pen
- Injection port
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Mail Order Pharmacies
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Product Type 6.2. Indication 6.3. Delivery Method 6.4. Distribution Channel 7. Global Market Analysis and Forecast, By Product Type 7.1. Detemir 7.2. Glargine 7.3. Degludec 8. Global Market Analysis and Forecast, By Indication 8.1. Type 1 diabetes 8.2. Type 2 diabetes 9. Global Market Analysis and Forecast, By Delivery Method 9.1. Pump 9.2. Needle and syringe 9.3. Pen 9.4. Injection port 10. Global Market Analysis and Forecast, By Distribution Channel 10.1. Hospital Pharmacies 10.2. Retail Pharmacies 10.3. Mail Order Pharmacies 11. Global Market Analysis and Forecast, By Region 11.1. North America 11.2. Latin America 11.3. Western Europe 11.4. Eastern Europe 11.5. East Asia 11.6. South Asia & Pacific 11.7. MEA 12. North America Sales Analysis and Forecast, by Key Segments and Countries 13. Latin America Sales Analysis and Forecast, by Key Segments and Countries 14. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 15. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 16. East Asia Sales Analysis and Forecast, by Key Segments and Countries 17. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries 18. MEA Sales Analysis and Forecast, by Key Segments and Countries 19. Sales Forecast by Product Type, Indication, Delivery Method, and Distribution Channel for 30 Countries 20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 21. Company Profile 21.1. Ganli Pharmaceutical Co. Ltd 21.2. Sanofi-Aventis U.S. LLC 21.3. Lilly USA 21.4. LLC 21.5. Novo Nordisk A/S 21.6. Biocon 21.7. Wockhardt 21.8. Mylan 21.9. Julphar
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Product Type
Table 3: Global Market US$ Mn Forecast by Indication
Table 4: Global Market US$ Mn Forecast by Delivery Method
Table 5: Global Market US$ Mn Forecast by Distribution Channel
Table 6: North America Market US$ Mn Forecast by Country
Table 7: North America Market US$ Mn Forecast by Product Type
Table 8: North America Market US$ Mn Forecast by Indication
Table 9: North America Market US$ Mn Forecast by Delivery Method
Table 10: North America Market US$ Mn Forecast by Distribution Channel
Table 11: Latin America Market US$ Mn Forecast by Country
Table 12: Latin America Market US$ Mn Forecast by Product Type
Table 13: Latin America Market US$ Mn Forecast by Indication
Table 14: Latin America Market US$ Mn Forecast by Delivery Method
Table 15: Latin America Market US$ Mn Forecast by Distribution Channel
Table 16: Western Europe Market US$ Mn Forecast by Country
Table 17: Western Europe Market US$ Mn Forecast by Product Type
Table 18: Western Europe Market US$ Mn Forecast by Indication
Table 19: Western Europe Market US$ Mn Forecast by Delivery Method
Table 20: Western Europe Market US$ Mn Forecast by Distribution Channel
Table 21: Eastern Europe Market US$ Mn Forecast by Country
Table 22: Eastern Europe Market US$ Mn Forecast by Product Type
Table 23: Eastern Europe Market US$ Mn Forecast by Indication
Table 24: Eastern Europe Market US$ Mn Forecast by Delivery Method
Table 25: Eastern Europe Market US$ Mn Forecast by Distribution Channel
Table 26: East Asia Market US$ Mn Forecast by Country
Table 27: East Asia Market US$ Mn Forecast by Product Type
Table 28: East Asia Market US$ Mn Forecast by Indication
Table 29: East Asia Market US$ Mn Forecast by Delivery Method
Table 30: East Asia Market US$ Mn Forecast by Distribution Channel
Table 31: South Asia & Pacific Market US$ Mn Forecast by Country
Table 32: South Asia & Pacific Market US$ Mn Forecast by Product Type
Table 33: South Asia & Pacific Market US$ Mn Forecast by Indication
Table 34: South Asia & Pacific Market US$ Mn Forecast by Delivery Method
Table 35: South Asia & Pacific Market US$ Mn Forecast by Distribution Channel
Table 36: MEA Market US$ Mn Forecast by Country
Table 37: MEA Market US$ Mn Forecast by Product Type
Table 38: MEA Market US$ Mn Forecast by Indication
Table 39: MEA Market US$ Mn Forecast by Delivery Method
Table 40: MEA Market US$ Mn Forecast by Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery Method
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 5: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery Method
Figure 9: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 13: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery Method
Figure 14: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 15: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 17: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 18: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery Method
Figure 19: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 20: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 22: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 23: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery Method
Figure 24: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 25: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 26: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 27: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 28: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery Method
Figure 29: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 30: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 31: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 32: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 33: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery Method
Figure 34: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 35: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 36: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 37: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 38: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery Method
Figure 39: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 40: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the growth outlook for long-acting insulin market by 2031?
According to Fact MR, the long-acting insulin market will experience substantial growth with a CAGR of 9.4% during the forecast period.
Which factors are driving the long-acting insulin market?
Insulin treatment, the prevalence of obesity and diabetes, increase in the geriatric population are driving the long-acting insulin market.
Which region dominates the long-acting insulin market until 2031?
Europe dominates the long-acting insulin market due to the presence of major players in the market and due to high geriatric population.
Long-Acting Insulin Market